We verified PIK3R3 and PTEN were the two targets of miR-186, and overexpression of miR-186 decreased the protein levels of PIK3R3 and PTEN in cisplatin-resistant ovarian cancer cells (Figures 4). This evidence concerns the gene PTEN and ovarian carcinoma.